Cambridge Investment Research Advisors’s ProShares MSCI Transformational Changes ETF ANEW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-4,411
Closed -$200K 3470
2024
Q3
$200K Buy
+4,411
New +$189K ﹤0.01% 3155
2024
Q2
Sell
-5,176
Closed -$215K 3318
2024
Q1
$215K Buy
+5,176
New +$205K ﹤0.01% 2969
2023
Q2
Sell
-6,064
Closed -$211K 3169
2023
Q1
$211K Buy
+6,064
New +$203K ﹤0.01% 2774
2022
Q4
Sell
-7,175
Closed -$211K 3108
2022
Q3
$211K Hold
7,175
﹤0.01% 2654
2022
Q2
$229K Buy
7,175
+19
+0.3% +$665 ﹤0.01% 2606
2022
Q1
$286K Buy
7,156
+678
+10% +$27.1K ﹤0.01% 2585
2021
Q4
$292K Sell
6,478
-153
-2% -$6.99K ﹤0.01% 2544
2021
Q3
$296K Buy
6,631
+287
+5% +$13.3K ﹤0.01% 2480
2021
Q2
$293K Buy
6,344
+907
+17% +$40.1K ﹤0.01% 2491
2021
Q1
$231K Buy
+5,437
New +$238K ﹤0.01% 2487

Other funds holding ANEW

Cambridge Investment Research Advisors's ANEW Position: Q4 2024 in Review

Cambridge Investment Research Advisors sold out of ProShares MSCI Transformational Changes ETF (ANEW) in Q4 2024, closing a stake of 4,411 shares — an estimated $200K sold.

Cambridge Investment Research Advisors first reported a position in ANEW in Q1 2021 and held it in 10 quarters. The position peaked at $296K in Q3 2021. 10 funds tracked by Wall St. Rank hold ANEW as of Q4 2024.

  • Cambridge Investment Research Advisors reported no remaining ProShares MSCI Transformational Changes ETF position as of Q4 2024 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 4,411 ProShares MSCI Transformational Changes ETF shares in Q4 2024, an estimated $200K.
  • Cambridge Investment Research Advisors first reported a position in ProShares MSCI Transformational Changes ETF in Q1 2021 and held it in 10 quarters.
  • Cambridge Investment Research Advisors's ProShares MSCI Transformational Changes ETF position peaked at $296K in Q3 2021.
  • 10 funds tracked by Wall St. Rank held ProShares MSCI Transformational Changes ETF as of Q4 2024.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.